Azithromycin combination for emesis control in dogs

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/7052 (2006.01) A61K 31/40 (2006.01) A61K 31/435 (2006.01) A61K 31/70 (2006.01) A61K 45/06 (2006.01) A61P 31/00 (2006.01)

Patent

CA 2290771

The invention is directed to a method of treating cancer or a bacterial or protozoal infection in a mammalian subject in need of such treatment. The method comprises the adjunctive administration of pharmaceutically effective amounts of a macrolide antibiotic and a Substance P antagonist. The invention also encompasses a method of preventing or treating emesis associated with macrolide antibiotic administration. The invention further encompasses novel compositions comprising a macrolide antibiotic and a Substance P antagonist.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Azithromycin combination for emesis control in dogs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Azithromycin combination for emesis control in dogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azithromycin combination for emesis control in dogs will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1373816

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.